Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

This study has been terminated.
(lack of enrollment)
National Institutes of Health (NIH)
Genentech, Inc.
Information provided by:
University of North Carolina, Chapel Hill Identifier:
First received: February 3, 2006
Last updated: June 26, 2009
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)